1. Rabieia Z, Hojjati MR, Rafieian-Kopaeiaa M, Alibabaeia Z. Effect of Cyperus rotundus tubers ethanolic extract on learning and memory in animal model of Alzheimer. Biomedicine & Aging Pathology. 2013; 3: 185-91. [
DOI:10.1016/j.biomag.2013.08.006]
2. Maczurek A, Hager K, Kenklies M, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev. 2008; 60: 1463-70. [
DOI:10.1016/j.addr.2008.04.015] [
PMID]
3. Rabiei Z, Asgharzadeh S, Bigdeli MR. Medicinal Herbs Effective in the Treatment of the Alzheimer's Disease. JBUMS. 2015; 16: 51-9.
4. Belkouch M, Hachem M, Elgot A, et al. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016; 38: 1-11. [
DOI:10.1016/j.jnutbio.2016.03.002] [
PMID]
5. Tanaka K, Farooqui AA, Siddiqi NJ, Alhomida AS, Ong WY. Effects of Docosahexaenoic Acid on Neurotransmission. Biomol Ther. 2012; 20: 152-7. [
DOI:10.4062/biomolther.2012.20.2.152] [
PMID] [
PMCID]
6. Solfrizzi V, D'Introno A, Colacicco AM, et al. Circulating biomarkers of cognitive decline and dementia. Clinica Chimica Acta. 2006; 364: 91-112. [
DOI:10.1016/j.cca.2005.06.015] [
PMID]
7. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res. 2009; 48: 239-56. [
DOI:10.1016/j.plipres.2009.04.001] [
PMID]
8. Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids. 2007; 77: 287-93. [
DOI:10.1016/j.plefa.2007.10.019] [
PMID]
9. Hashimoto M, Hossain S. Neuroprotective and Ameliorative Actions of Polyunsaturated Fatty Acids Against Neuronal Diseases: Beneficial Effect of Docosahexaenoic Acid on Cognitive Decline in Alzheimer's Disease. J Pharmacol Sci. 2011; 116: 150-62. [
DOI:10.1254/jphs.10R33FM]
10. Moreira P, Zhu X, Liu Q, et al. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol Res. 2006; 39: 7-13. [
DOI:10.4067/S0716-97602006000100002] [
PMID]
11. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000; 19: 1784-93. [
DOI:10.1093/emboj/19.8.1784] [
PMID] [
PMCID]
12. Pan HC, Kao TK, Ou YC, et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem. 2009; 20: 715-25. [
DOI:10.1016/j.jnutbio.2008.06.014] [
PMID]
13. Berman DR, Liu YQ, Barks J, Mozurkewich E. Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am J Obstet Gynecol. 2010; 202: 469. e1-6. [
DOI:10.1016/j.ajog.2010.01.076] [
PMID] [
PMCID]
14. Ashkavandi S, Moazedi AA, Semnanian S, Eshagh-Harooni H, Mohammadi T, Pourmehdi-Boroujeni M. The effect of methylprednisolone on spatial learning and memory in adult male rats using an experimental model of Alzheimer's disease. Feyz. 2015; 19: 102-10.
15. Hoveida R, Moazedi AA, Rasekh AR. The effect of intra-Hippocampal CA1 area injection of Estradiol Benzoate on the spatial learning and memory in adult male rats. Modares J Med Sci. 2005; 7: 115-24.
16. Abraham IM, Koszegi Z, Tolod-Kemp E, Szego EM. Action of estrogen on survival of basal forebrain cholinergic neurons: Promoting amelioration. Psychoneuroendocrinology. 2009; 1: S104-12. [
DOI:10.1016/j.psyneuen.2009.05.024] [
PMID]
17. Zahedi M, Hojjati MR, Fathpour H, Rabiei Z, Alibabaei Z, Basim A. Effect of Rheum Ribes Hydro-Alcoholic Extract on Memory Impairments in Rat Model of Alzheimers Disease. Iran J Pharm Res. 2015; 14: 1197-206.
18. Dabir N, Moazedi AA, Haghparast A, Khajepour L, Akhoond M. Effects
19. of Estrogen Therapy on Cognitive Performance Deficit Induced by Nucleus Basalis Magnocellularis Lesion: Animal Model of Alzheimer's Disease. J Isfahan Med Sch. 2016; 34: 1-10.
20. Goshadrou F. Modified sensory processing in the barrel cortex of the Rat model of Alzheimer's disease. J Gorgan Uni Med Sci. 2011; 13: 16-25.
21. Figueroa JD, Cordero K, Baldeosingh K, et al. Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J Neurotrauma. 2012; 29: 551-66. [
DOI:10.1089/neu.2011.2141] [
PMID] [
PMCID]
22. Hong SH, Belayev L, Khoutorova L, Obenaus A, Bazan NG. Docosahexaenoic acid confers enduring neuroprotection in experimental stroke. J Neurol Sci. 2014; 338: 135-41. [
DOI:10.1016/j.jns.2013.12.033] [
PMID] [
PMCID]
23. Berman DR, Mozurkewich E, Liu Y, Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol. 2009; 200: 305. e1-6. [
DOI:10.1016/j.ajog.2009.01.020] [
PMID] [
PMCID]
24. Palacios-Pelaez R, Lukiw WJ, Bazan NG. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol. 2010; 41: 367-74. [
DOI:10.1007/s12035-010-8139-z] [
PMID]
25. Jiang LH, Shi Y, Wang LS, Yang ZR. The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice. J Nutr Biochem. 2009; 20: 735-41. [
DOI:10.1016/j.jnutbio.2008.07.003] [
PMID]
26. Kim HY, Spector AA, Xiong ZM. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat. 2011; 96: 114-20. [
DOI:10.1016/j.prostaglandins.2011.07.002] [
PMID] [
PMCID]
27. Hashimoto M, Hossain S, Shimada T, et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 2002; 81: 1084-91. [
DOI:10.1046/j.1471-4159.2002.00905.x] [
PMID]
28. Robson LG, Dyall S, Sidloff D, Michael-Titus AT. Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol Aging. 2010; 31: 678-87. [
DOI:10.1016/j.neurobiolaging.2008.05.027] [
PMID]
29. Calderon F, Kim HY. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem. 2004; 90: 979-88. [
DOI:10.1111/j.1471-4159.2004.02520.x] [
PMID]
30. de Wilde MC, Penke B, van der Beek EM, Kuipers AA, Kamphuis PJ, Broersen LM. Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats. J Alzheimers Dis. 2011; 27: 327-39. [
DOI:10.3233/JAD-2011-110635] [
PMID]
31. Favreliere S, Perault MC, Huguet F, et al. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging. 2003; 24: 233-43. [
DOI:10.1016/S0197-4580(02)00064-7]
32. Högyes E, Nyakas C, Kiliaan A, Farkas T, Penke B, Luiten PG. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience. 2003; 119: 999-1012. [
DOI:10.1016/S0306-4522(03)00198-2]
33. Nishikawa M, Kimura S, Akaike N. Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate responses in pyramidal neurons of rat cerebral cortex. J Physiol. 1994; 475: 83-93. [
DOI:10.1113/jphysiol.1994.sp020051] [
PMID]
34. Hamano H, Nabekura J, Nishikawa M, Ogawa T. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J Neurophysiol. 1996; 75: 1264-70. [
DOI:10.1152/jn.1996.75.3.1264] [
PMID]